应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LMAT 勒梅特微管医疗
休市中 05-03 16:00:00 EDT
74.22
+7.45
+11.16%
盘后
72.75
-1.47
-1.98%
17:00 EDT
最高
74.45
最低
69.82
成交量
33.00万
今开
72.00
昨收
66.77
日振幅
6.93%
总市值
16.66亿
流通市值
14.95亿
总股本
2,245万
成交额
2,390万
换手率
1.64%
流通股本
2,014万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
摩根大通证券公司:维持LeMaitre Vascular(LMAT.US)评级,由优于大市调整至优于大市评级, 目标价由72.00美元调整至77.00美元。
智通财经 · 05-04 03:15
摩根大通证券公司:维持LeMaitre Vascular(LMAT.US)评级,由优于大市调整至优于大市评级, 目标价由72.00美元调整至77.00美元。
LeMaitre Vascular Inc 预计每股收益39美分 - 财报前瞻
Reuters · 05-01
LeMaitre Vascular Inc 预计每股收益39美分 - 财报前瞻
勒梅特微管医疗盘中异动 早盘股价大涨5.45%
自选股智能写手 · 04-26
勒梅特微管医疗盘中异动 早盘股价大涨5.45%
勒梅特微管医疗2023财年实现净利润30.11百万美元,同比增加45.88%
自选股智能写手 · 03-03
勒梅特微管医疗2023财年实现净利润30.11百万美元,同比增加45.88%
勒梅特微管医疗盘中异动 早盘股价大跌5.01%报67.50美元
自选股智能写手 · 02-29
勒梅特微管医疗盘中异动 早盘股价大跌5.01%报67.50美元
勒梅特微管医疗盘中异动 股价大涨9.48%报68.00美元
自选股智能写手 · 02-28
勒梅特微管医疗盘中异动 股价大涨9.48%报68.00美元
LeMaitre Vascular Inc 预计每股收益 36 美分 - 财报前瞻
Reuters · 02-24
LeMaitre Vascular Inc 预计每股收益 36 美分 - 财报前瞻
勒梅特微管医疗盘中异动 股价大涨5.01%报52.21美元
自选股智能写手 · 2023-11-15
勒梅特微管医疗盘中异动 股价大涨5.01%报52.21美元
暂无数据
公司概况
公司名称:
勒梅特微管医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lemaitre Vascular, Inc.是一家全球化的供应商,提供治疗周围性血管疾病的医疗设备和植入器械。公司1983年11月28日成立。公司开发、制造和销售满足血管外科所需的治疗器械。公司的各种外围血管装置包括用于心脏以外动静脉(也称为血管外科)的品牌产品,包括可拓展的LeMaitre心脏瓣膜刀、Pruitt F3颈动脉分流器、VascuTape不透射线胶带。 从历史上看,公司一直是血管外科产品的领先供应商,面向较低或限制竞争的利基市场。最近公司希望利用利基市场的市场领导地位转而向更大、更具竞争力的市场出售综合配套产品。此外,公司的血管外科产品客户正逐渐涉及微创血管内部治疗,这为公司提供了一个良好的机会出售新产品解决新需求。
发行价格:
--
{"stockData":{"symbol":"LMAT","market":"US","secType":"STK","nameCN":"勒梅特微管医疗","latestPrice":74.22,"timestamp":1714766400000,"preClose":66.77,"halted":0,"volume":329984,"hourTrading":{"tag":"盘后","latestPrice":72.75,"preClose":74.22,"latestTime":"17:00 EDT","volume":4587,"amount":340150.15,"timestamp":1714770001489},"delay":0,"floatShares":20139071,"shares":22445999,"eps":1.34,"marketStatus":"休市中","marketStatusCode":7,"change":7.45,"latestTime":"05-03 16:00:00 EDT","open":72,"high":74.45,"low":69.82,"amount":23903100.5056,"amplitude":0.069343,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.34,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1161230400000,"adjPreClose":66.77,"adrRate":0,"dividendRate":0.007815,"preHourTrading":{"tag":"盘前","latestPrice":69.64,"preClose":66.77,"latestTime":"09:28 EDT","volume":248,"amount":16781.220080000003,"timestamp":1714742896125},"postHourTrading":{"tag":"盘后","latestPrice":72.75,"preClose":74.22,"latestTime":"17:00 EDT","volume":4587,"amount":340150.15,"timestamp":1714770001489},"volumeRatio":2.1604634341980162},"requestUrl":"/m/hq/s/LMAT/tweets","defaultTab":"tweets","newsList":[{"id":"2432673133","title":"摩根大通证券公司:维持LeMaitre Vascular(LMAT.US)评级,由优于大市调整至优于大市评级, 目标价由72.00美元调整至77.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432673133","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432673133?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:15","pubTimestamp":1714763725,"startTime":"0","endTime":"0","summary":"摩根大通证券公司:维持LeMaitre Vascular(LMAT.US)评级,由优于大市调整至优于大市评级, 目标价由72.00美元调整至77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403152787cf437d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403152787cf437d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432534767","title":"LeMaitre Vascular Inc 预计每股收益39美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432534767","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432534767?lang=zh_cn&edition=full","pubTime":"2024-05-01 05:57","pubTimestamp":1714514228,"startTime":"0","endTime":"0","summary":" * LeMaitre Vascular Inc 将于5月2日公布截至2024年3月31日的季度财报,预计该公司的季度收入将有所增长。* LSEG 的分析师平均预计 LeMaitre Vascular Inc 的每股收益为 39 美分。* 华尔街对 LeMaitre Vascular Inc 的 12 个月目标价中值为 71.00 美元,高于其上一交易日的收盘价 66.24 美元。4月30日 - 该公司2024年2月27日发布的截至3月31日的业绩指导是:息税前利润为970万至1130万美元。以前的季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430270672","title":"勒梅特微管医疗盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430270672","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430270672?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:35","pubTimestamp":1714138535,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时35分,勒梅特微管医疗股票出现异动,股价急速拉升5.45%。截至发稿,该股报66.43美元/股,成交量1.0486万股,换手率0.05%,振幅2.73%。勒梅特微管医疗股票所在的医疗设备行业中,整体涨幅为0.40%。勒梅特微管医疗公司简介:LeMaitre Vascular Inc 制造和分销用于治疗周围血管疾病的医疗设备。消息层面,截至21时35分,《Stifel:上调LeMaitre Vascular评级,由持有调整至买入评级, 目标价由59.00美元调整至75.00美元。》资讯为影响勒梅特微管医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262135367923f9d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262135367923f9d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416495964","title":"勒梅特微管医疗2023财年实现净利润30.11百万美元,同比增加45.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416495964","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416495964?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:26","pubTimestamp":1709396797,"startTime":"0","endTime":"0","summary":"12月31日,勒梅特微管医疗公布财报,公告显示公司2023财年净利润为30.11百万美元,同比增加45.88%;其中营业收入为1.93亿美元,同比增加19.14%,每股基本收益为1.36美元。从资产负债表来看,勒梅特微管医疗总负债48.88百万美元,其中短期债务2.47百万美元,资产负债比为0.08,流动比率为0.07。机构评级:截至2023年12月31日,当前有7家机构对勒梅特微管医疗目标价做出预测,其中目标均价为71.29美元,其中最低目标价为59.00美元,最高目标价为84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030026498afa677e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030026498afa677e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415523265","title":"勒梅特微管医疗盘中异动 早盘股价大跌5.01%报67.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415523265","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415523265?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:48","pubTimestamp":1709218137,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时48分,勒梅特微管医疗股票出现波动,股价快速下挫5.01%。截至发稿,该股报67.50美元/股,成交量1.9166万股,换手率0.09%,振幅4.90%。勒梅特微管医疗股票所在的医疗设备行业中,整体涨幅为0.18%。勒梅特微管医疗公司简介:LeMaitre Vascular Inc生产和分销用于治疗周围血管疾病的医疗设备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292248577915f97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292248577915f97c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415532761","title":"勒梅特微管医疗盘中异动 股价大涨9.48%报68.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415532761","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415532761?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:30","pubTimestamp":1709130658,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时30分,勒梅特微管医疗股票出现异动,股价大幅拉升9.48%。截至发稿,该股报68.00美元/股,成交量7326股,换手率0.03%,振幅0.00%。勒梅特微管医疗股票所在的医疗设备行业中,整体跌幅为0.48%。其相关个股中,勒梅特微管医疗、Avinger Inc、Femasys Inc涨幅较大,Femasys Inc、Bionano Genomics Inc、Microbot Medical Inc较为活跃,换手率分别为3.09%、0.30%、0.11%,振幅较大的相关个股有勒梅特微管医疗、Akoya Biosciences Inc、ICU医疗,振幅分别为4.83%、3.42%、2.98%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822305879158bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822305879158bca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413746761","title":"LeMaitre Vascular Inc 预计每股收益 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413746761","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413746761?lang=zh_cn&edition=full","pubTime":"2024-02-24 08:35","pubTimestamp":1708734941,"startTime":"0","endTime":"0","summary":" * LeMaitre Vascular Inc 将于2月27日发布截至2023年12月31日的季度业绩报告,预计该公司的季度收入将有所增长。* 根据LSEG的数据,9位分析师的平均预期显示,这家总部位于马萨诸塞州伯灵顿的公司的营收预计将从去年同期的4095万美元增长19.7%,达到4902.1万美元。 * LSEG 的分析师平均预计 LeMaitre Vascular Inc 每股收益为 36 美分。* 华尔街对 LeMaitre Vascular Inc 的 12 个月目标价中位数为 63.00 美元,高于其上次收盘价 62.19 美元。以前的季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2383078043","title":"勒梅特微管医疗盘中异动 股价大涨5.01%报52.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2383078043","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383078043?lang=zh_cn&edition=full","pubTime":"2023-11-15 04:47","pubTimestamp":1699994830,"startTime":"0","endTime":"0","summary":"北京时间2023年11月15日04时47分,勒梅特微管医疗股票出现异动,股价大幅拉升5.01%。截至发稿,该股报52.21美元/股,成交量14.5255万股,换手率0.65%,振幅3.92%。最近的财报数据显示,该股实现营业收入47.41百万美元,净利润7.50百万美元,每股收益0.34美元,毛利29.28百万美元,市盈率42.70倍。勒梅特微管医疗股票所在的医疗设备行业中,整体涨幅为2.47%。勒梅特微管医疗公司简介:LeMaitre Vascular Inc生产和分销用于治疗周围血管疾病的医疗设备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231115044710839c9b08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231115044710839c9b08&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lemaitre.com","stockEarnings":[{"period":"1week","weight":0.1338},{"period":"1month","weight":0.1637},{"period":"3month","weight":0.2644},{"period":"6month","weight":0.5306},{"period":"1year","weight":0.1378},{"period":"ytd","weight":0.3076}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lemaitre Vascular, Inc.是一家全球化的供应商,提供治疗周围性血管疾病的医疗设备和植入器械。公司1983年11月28日成立。公司开发、制造和销售满足血管外科所需的治疗器械。公司的各种外围血管装置包括用于心脏以外动静脉(也称为血管外科)的品牌产品,包括可拓展的LeMaitre心脏瓣膜刀、Pruitt F3颈动脉分流器、VascuTape不透射线胶带。 从历史上看,公司一直是血管外科产品的领先供应商,面向较低或限制竞争的利基市场。最近公司希望利用利基市场的市场领导地位转而向更大、更具竞争力的市场出售综合配套产品。此外,公司的血管外科产品客户正逐渐涉及微创血管内部治疗,这为公司提供了一个良好的机会出售新产品解决新需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.006721},{"month":2,"riseRate":0.555556,"avgChangeRate":0.020588},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.006655},{"month":4,"riseRate":0.611111,"avgChangeRate":0.030507},{"month":5,"riseRate":0.666667,"avgChangeRate":0.018018},{"month":6,"riseRate":0.647059,"avgChangeRate":0.047355},{"month":7,"riseRate":0.764706,"avgChangeRate":0.067313},{"month":8,"riseRate":0.588235,"avgChangeRate":0.018014},{"month":9,"riseRate":0.529412,"avgChangeRate":0.008074},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.036609},{"month":11,"riseRate":0.722222,"avgChangeRate":0.032314},{"month":12,"riseRate":0.666667,"avgChangeRate":0.009078}],"exchange":"NASDAQ","name":"勒梅特微管医疗","nameEN":"LeMaitre Vascular"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"勒梅特微管医疗(LMAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供勒梅特微管医疗(LMAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"勒梅特微管医疗,LMAT,勒梅特微管医疗股票,勒梅特微管医疗股票老虎,勒梅特微管医疗股票老虎国际,勒梅特微管医疗行情,勒梅特微管医疗股票行情,勒梅特微管医疗股价,勒梅特微管医疗股市,勒梅特微管医疗股票价格,勒梅特微管医疗股票交易,勒梅特微管医疗股票购买,勒梅特微管医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"勒梅特微管医疗(LMAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供勒梅特微管医疗(LMAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}